X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (18) 18
index medicus (18) 18
hematology (10) 10
prognosis (8) 8
abridged index medicus (7) 7
cell line, tumor (7) 7
female (7) 7
multiple myeloma (7) 7
multiple myeloma - drug therapy (7) 7
multiple myeloma - pathology (7) 7
oncology (7) 7
lymphoid neoplasia (6) 6
male (6) 6
middle aged (6) 6
aged (5) 5
animals (5) 5
chromosome aberrations (5) 5
mice (5) 5
mice, scid (5) 5
multiple myeloma - genetics (5) 5
multiple myeloma - immunology (5) 5
102 (4) 4
abnormalities (4) 4
adult (4) 4
cell proliferation - drug effects (4) 4
classification (4) 4
disease-free survival (4) 4
hemic and lymphatic diseases (4) 4
immune system diseases (4) 4
multiple myeloma - metabolism (4) 4
survival (4) 4
acrylamides - pharmacology (3) 3
antineoplastic agents - pharmacology (3) 3
antitumor-activity (3) 3
apoptosis (3) 3
article (3) 3
bone-marrow (3) 3
bortezomib (3) 3
cancer (3) 3
chronic lymphocytic-leukemia (3) 3
drug-resistance (3) 3
immunosuppression (3) 3
in situ hybridization, fluorescence (3) 3
kaplan-meier estimate (3) 3
lymphocytes (3) 3
multiple myeloma - mortality (3) 3
nicotinamide phosphoribosyltransferase (3) 3
nicotinamide phosphoribosyltransferase - metabolism (3) 3
osteoclasts - metabolism (3) 3
patients (3) 3
piperidines - pharmacology (3) 3
plasma-cells (3) 3
aged, 80 and over (2) 2
antibodies, monoclonal - pharmacology (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
apoptosis - drug effects (2) 2
b-lymphocytes - drug effects (2) 2
baff (2) 2
bcma (2) 2
biomarkers, tumor - genetics (2) 2
biomarkers, tumor - metabolism (2) 2
bone marrow (2) 2
bone marrow - pathology (2) 2
cell maturation antigen (2) 2
cell proliferation (2) 2
cell survival (2) 2
cell survival - drug effects (2) 2
cells (2) 2
cells, cultured (2) 2
conventional t (2) 2
cytogenetics (2) 2
cytokines - metabolism (2) 2
dendritic cells (2) 2
design (2) 2
drug synergism (2) 2
fk866 (2) 2
foxp3 protein (2) 2
gene expression (2) 2
gene expression regulation, neoplastic (2) 2
growth (2) 2
health aspects (2) 2
hematology, oncology and palliative medicine (2) 2
immunoregulation (2) 2
in-situ hybridization (2) 2
in-vitro (2) 2
inflammation mark (2) 2
inhibition (2) 2
interleukin 10 (2) 2
lenalidomide plus dexamethasone (2) 2
lymphocytes t (2) 2
medical colleges (2) 2
microenvironment (2) 2
monoclonal antibodies (2) 2
multiple myeloma - blood (2) 2
multiple myeloma - enzymology (2) 2
multiple myeloma - therapy (2) 2
multiple-myeloma (2) 2
mutation (2) 2
mutation - genetics (2) 2
nad - metabolism (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Cancer Research, ISSN 1078-0432, 08/2017, Volume 23, Issue 15, pp. 4290 - 4300
Purpose: We study CD38 levels in immunosuppressive CD4(+)CD25(high)Foxp3(+) regulatory T cells (Treg) and further define immunomodulating effects of a... 
IN-VITRO | MICROENVIRONMENT | ONCOLOGY | IMMUNOTHERAPY | LENALIDOMIDE | DARATUMUMAB MONOTHERAPY | PERIPHERAL-BLOOD | PROLIFERATION | ANTITUMOR-ACTIVITY | CARCINOMA | CANCER | Leukocytes, Mononuclear - drug effects | Immunosuppression - methods | Cell Count | Humans | Interleukin-10 - blood | Multiple Myeloma - immunology | Immunologic Memory - drug effects | Transforming Growth Factor beta - blood | ADP-ribosyl Cyclase 1 - blood | T-Lymphocytes, Regulatory - immunology | Multiple Myeloma - drug therapy | Multiple Myeloma - pathology | T-Lymphocytes, Regulatory - drug effects | Antibodies, Monoclonal - administration & dosage | Immunosuppressive Agents - immunology | ADP-ribosyl Cyclase 1 - immunology | Cell Line, Tumor | Female | Gene Expression Regulation, Neoplastic - drug effects | Immunosuppressive Agents - administration & dosage | Immune Tolerance - drug effects | Multiple Myeloma - blood | Plasma | CD8 antigen | Multiple myeloma | Bone marrow transplantation | Recovery of function | Leukocytes (mononuclear) | Lymphocytes T | Immunosuppressive agents | Killer cells | Lymphocytes | CD38 antigen | Interleukin 1 | Bone marrow | Peripheral blood mononuclear cells | CD25 antigen | Foxp3 protein | Inhibition | Natural killer cells | Immunoregulation | Patients | CD4 antigen | Immunosuppression | Experimental design | Interleukin 10 | Lysis | Monoclonal antibodies | Health risk assessment | Cancer | IFNγ | CD107a | bone marrow stromal cells (BMSCs) | natural occurring Tregs (nTregs) | regulatory T (Treg) | CD38 | Isatuximab (Isa) (SAR650984) | PD1 | multiple myeloma (MM) | conventional T (Tcon) | tumor-induced Treg (iTregs)
Journal Article
Probiotics and antimicrobial proteins, ISSN 1867-1306, 03/2019
To screen Bacillus clausii UBBC07 as a putative probiotic strain and to examine the protective effect of probiotic-B. clausii UBBC07 spore on uremia on rats... 
Journal Article
Leukemia, ISSN 0887-6924, 02/2019, Volume 33, Issue 2, pp. 426 - 438
We investigate here how APRIL impacts immune regulatory T cells and directly contributes to the immunosuppressive multiple myeloma (MM) bone marrow (BM)... 
B-CELLS | BAFF | MATURATION ANTIGEN | IMMUNE STATUS | MICROENVIRONMENT | ONCOLOGY | BONE-MARROW | GROWTH | BCMA | CHIMERIC ANTIGEN RECEPTOR | HEMATOLOGY | PLASMA-CELLS | Signal Transduction | Antibodies, Monoclonal - pharmacology | Humans | Cells, Cultured | Gene Expression Regulation, Neoplastic | Multiple Myeloma - immunology | Multiple Myeloma - metabolism | Osteoclasts - cytology | Osteoclasts - metabolism | Tumor Necrosis Factor Ligand Superfamily Member 13 - metabolism | T-Lymphocytes, Regulatory - immunology | Transmembrane Activator and CAML Interactor Protein - metabolism | Transmembrane Activator and CAML Interactor Protein - genetics | Immunosuppression | Multiple Myeloma - drug therapy | Osteoclasts - immunology | Immune Tolerance - immunology | Biomarkers, Tumor - metabolism | Tumor Necrosis Factor Ligand Superfamily Member 13 - genetics | Biomarkers, Tumor - genetics | Immunosuppressive Agents - pharmacology | Osteoclasts - drug effects | Cell survival | Immunoregulation | Multiple myeloma | Lymphocytes T | Survival | Patients | APRIL protein | Signaling | CTLA-4 protein | Biomedical materials | Lymphocytes B | Lymphocytes | PD-L1 protein | Interleukin 10 | Cell cycle | Bone marrow | Monoclonal antibodies | Foxp3 protein | Biocompatibility | Osteoclasts | Combined treatment | Apoptosis | regulatory T (Treg) | TGFβ | Transmembrane Activator and CAML Interactor (TACI) | tumor growth factor beta | Osteoclast (OC) | multiple myeloma (MM) | interleukin-10 | A proliferation inducing ligand (APRIL) | conventional T (Tcon) | IL-10 | tumor-induced Treg (iTregs)
Journal Article
AJIC: American Journal of Infection Control, ISSN 0196-6553, 2016, Volume 44, Issue 12, pp. 1495 - 1504
Journal Article
Blood, ISSN 0006-4971, 05/2014, Volume 123, Issue 20, pp. 3128 - 3138
Journal Article
Journal Article
Annals of Hematology, ISSN 0939-5555, 2/2015, Volume 94, Issue 2, pp. 257 - 264
Journal Article
Blood, ISSN 0006-4971, 08/2012, Volume 120, Issue 9, pp. 1877 - 1887
Journal Article